{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-301477","form_type":"8-K","ticker":"CME","cik":"0001156375","company_name":"CME GROUP INC.","filed_at":"2022-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.756365+00:00","generated_at":"2026-06-21T06:39:55.249407+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"CME Group amends bylaws for Universal Proxy Rules compliance, removes Class B Nominating Committee references","bullets":["Board approved and adopted Amended Bylaws effective Dec 7, 2022, addressing Universal Proxy Rule 14a-19.","Requires evidence of shareholder compliance with Universal Proxy solicitation requirements.","Company provided a remedy if a shareholder fails to satisfy Universal Proxy Rules.","Removed references to Class B Nominating Committees, which concluded as of 2020 Annual Meeting.","Also includes non-substantive and clarifying changes to Bylaws."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-301477","json":"https://secwatch.observer/filing/0001193125-22-301477.json","markdown":"https://secwatch.observer/filing/0001193125-22-301477.md","text":"https://secwatch.observer/filing/0001193125-22-301477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/0001193125-22-301477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/d412380d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T06:39:55.249407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"66f871da3b7a674882aca46650e98be833068dd0","claim":"CME GROUP INC.: Amended and Restated Bylaws to address Universal Proxy Rules, including shareholder solicitation requirements and removal of Class B Nominating Committee references (effective 2022-12-07).","evidence_excerpt":"On December 7, 2022, the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) approved and adopted Amended and Restated Bylaws of the Corporation (the “Amended Bylaws”), effective December 7, 2022, in order to, among other things, address matters relating to Rule 14a-19 (the “Universal Proxy Rules”) under the Securities Exchange Act of 1934, as amended.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312522301477/0001193125-22-301477-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-12-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}